Peripheral neuropathy linked to heart risk

THE study in 13,000 primary care patients without cardiovascular disease at baseline, showed that survival after 30 months of follow-up was 89.4% among patients with peripheral neuropathy, compared with 94.4% among patients without, after adjusting for HbA1c.